| |
|
|
|
Cleveland Biolabs  
|
|
4.1772 0.237 (0.06%) |
01-25 12:51 |
|
Open: |
3.98 |
Pre close: |
3.94 |
Target:
|
5.17
|
|
High: |
4.2 |
Low: |
3.8281 |
Resistance:
|
4.43
5.17
|
|
Volume: |
197,925 |
Market Cap: |
54M |
Support:
|
3.37
2.71
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.97
 |
MACD |
MACD(12,26):
|
0.22 |
|
MA(20): |
3.73 |
Signal(12,26,9): |
0.20 |
|
MA(100): |
2.81 |
Stochastic Oscillator |
%K(14,3):
|
61.77  |
|
MA(250): |
2.43 |
%D(3): |
61.26 |
|
Average Volume(K) |
3-Month: |
32744
|
52-Week |
High:
|
5.43 |
|
10-Days: |
38020 |
Low: |
1.27 |
|
RSI |
RSI(14):
|
65.96 |
Change(%): |
46.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.203 |
Return on Equity (ttm) |
-110.5 |
Shares Out. (M) |
13.02 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-47.8 |
Shares Float (M) |
5.99 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
56.41 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-83.8 |
% Held by Institutions |
6.67 |
|
Forward EPS |
-0.280 |
Gross Profit (p.s.) |
-0.042 |
Shares Short (K) |
248 |
|
Book Value (p.s.) |
-0.170 |
EBITDA (p.s.) |
-0.160 |
P/E |
-20.07 |
|
Sales Per Share |
0.049 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-23.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-1.95 |
P/S |
83.96 |
|
Operating Margin |
-330.82 |
Levered Free Cash Flow
(M) |
-1.54 |
P/CF |
-27.20 |
|
|
|
|
|
|
